{"product_id":"psychiatry-of-intellectual-disability-isbn-9781119993810","title":"Psychiatry of Intellectual Disability","description":"Patients with intellectual disability (ID) can benefit from the full range of mental health services. To ensure that psychiatric assessment, diagnosis and treatment interventions are relevant and effective; individuals with ID should be evaluated and treated within the context of their developmental framework. Behavior should be viewed as a form of communication.  \u003cp\u003eIndividuals with ID often present with behavioral symptoms complicated by limited expressive language skills and undiagnosed medical conditions. Many training programs do not include focused study of individuals with ID, despite the fact that patients with ID will be seen by virtually every mental health practitioner. In this book, the authors present a framework for competent assessment and treatment of psychiatric disorders in individuals with ID.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003ci\u003ePsychiatry of Intellectual Disability\u003c\/i\u003e\u003c\/b\u003e is a resource guide for psychiatrists, nurse practitioners, and other prescribers treating patients with ID. It is a supplemental text for psychiatry residents, medical students, psychology graduate students, psychotherapists, counselors, social workers, behavior support specialists and nurses. To assist the practicing clinician the book includes:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eClinical vignettes\u003c\/li\u003e \u003cli\u003eClinical pearls\u003c\/li\u003e \u003cli\u003eCharts for quick reference\u003c\/li\u003e \u003cli\u003eIssues concerning medications and poly-pharmacy\u003c\/li\u003e \u003cli\u003eAltered diagnostic criteria specific for use with individuals with ID\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eThere are no evidence-based principles dedicated to psychotropic medication use in ID, but consensus guidelines address the high prevalence of poly-pharmacy. Altered diagnostic criteria have been published which accommodate less self-report and incorporate collateral information; this book reviews the literature on psychotropic medications, consensus guidelines, and population-specific diagnostic criteria sets.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003ci\u003ePsychiatry of Intellectual Disability\u003c\/i\u003e\u003c\/b\u003e also includes:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eInterviewing techniques and assessment tips for all levels of communicative ability as well as for nonverbal individuals\u003c\/li\u003e \u003cli\u003eAssessment of aggression to determine etiology and formulate a treatment plan\u003c\/li\u003e \u003cli\u003eOverview of types of psychotherapy and suggested alterations for each to increase efficacy\u003c\/li\u003e \u003cli\u003eRelevant legal issues for caregivers and treatment providers\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eThe detective work involved in mental health assessment of individuals with ID is challenging yet rewarding. The highest quality mental health treatment limits hospital days, improves quality of life and often allows individuals to live in the least restrictive environments. \u003cb\u003e\u003ci\u003ePsychiatry of Intellectual Disability\u003c\/i\u003e\u003c\/b\u003e is a must have resource for clinicians treating the ID population.\u003c\/p\u003e \u003cp\u003eDedications vii\u003c\/p\u003e \u003cp\u003eEditor biographies ix\u003c\/p\u003e \u003cp\u003eList of contributors xi\u003c\/p\u003e \u003cp\u003eList of abbreviations xiii\u003c\/p\u003e \u003cp\u003eForeword xv\u003c\/p\u003e \u003cp\u003e1 Overview 1\u003cbr\u003e \u003ci\u003eAllison E. Cowan, MD and Julie P. Gentile, MD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Psychiatric Assessment 14\u003cbr\u003e \u003ci\u003eAnn K. Morrison, MD and Paulette Marie Gillig, MD, PhD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Medical Assessment 26\u003cbr\u003e \u003ci\u003eJulie P. Gentile, MD and Michelle A. Monro, DO\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Neurologic Conditions 51\u003cbr\u003e \u003ci\u003ePaulette Marie Gillig, MD, PhD and Richard Sanders, MD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Traumatic Brain Injuries and Co-occurring Mental Illness 75\u003cbr\u003e \u003ci\u003eGretchen N. Foley, MD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Interviewing Techniques 90\u003cbr\u003e \u003ci\u003eJulie P. Gentile, MD and Paulette Marie Gillig, MD, PhD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Mood Disorders 125\u003cbr\u003e \u003ci\u003eAnn K. Morrison, MD and Christina Weston, MD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Anxiety Disorders 146\u003cbr\u003e \u003ci\u003eKelly M. Blankenship, MD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Psychotic Disorders 161\u003cbr\u003e \u003ci\u003eAllison E. Cowan, MD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Personality Disorders 191\u003cbr\u003e \u003ci\u003eJulie P. Gentile, MD and Allison E. Cowan, MD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Aggression 210\u003cbr\u003e \u003ci\u003eJulie P. Gentile, MD and Paulette Marie Gillig, MD, PhD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Psychotropic Medications 250\u003cbr\u003e \u003ci\u003eChristopher T. Manetta, DO and Julie P. Gentile, MD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Psychotherapy 278\u003cbr\u003e \u003ci\u003eCarroll S. Jackson, LISW-S and Julie P. Gentile, MD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Behavioral Assessment and Interventions 309\u003cbr\u003e \u003ci\u003eBetsey A. Benson, PhD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Legal Issues for Treatment Providers and Evaluators 325\u003cbr\u003e \u003ci\u003eJeannette Cox, JD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Syndromes of Intellectual Disability 338\u003cbr\u003e \u003ci\u003eKelly M. Blankenship, MD and Christina Weston, MD\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 366\u003c\/p\u003e  \u003cp\u003e\"..the book easily surpasses its goal to serve as a manual for the psychiatric treatment of this population, as the chapters provide a solid overview of the subject matter,including contemporary references.\u003c\/p\u003e \u003cp\u003e\u003ci\u003ePsychiatry of Intellectual Disability: A Practical Manual\u003c\/i\u003e will definitely appeal to those who spend the majority of their professional time providing psychiatric care to individuals with intellectual disabilities as well as to those with less frequent contact with this patient group.\" (\u003ci\u003eJournal of Clinical Psychiatry\u003c\/i\u003e, 2013)\u003c\/p\u003e \u003cp\u003e\u003cbr\u003e \u003cbr\u003e “This is a superb and extremely helpful book on the diagnosis and management of patients with intellectual disability. I wish this book were available when I was in training!.”  (\u003ci\u003eDoody's\u003c\/i\u003e, 12 October 2012)\u003c\/p\u003e \"This is a good source of practical information directed at clinicians in the field. Drs. Gentile and Gillig provide us with a concise well referenced survey of the rapidly developing field of community-based management of complex neurobehavioral and psychiatric conditions.\" (\u003ci\u003eThe NADD Bulletin, 2012\u003c\/i\u003e)  \u003cp\u003e\u003ci\u003eJulie P. Gentile, M.D.\u003c\/i\u003e (jen-TILL-ee) is Associate Professor of Psychiatry at the Boonshoft School of Medicine, Wright State University, Dayton, Ohio and the Project Director for Ohio’s Coordinating Center of Excellence in Mental Illness\/Intellectual Disability. She has been the Professor of Dual Diagnosis for the Ohio Department of Mental Health, the Ohio Department of Developmental Disability, and the Ohio Developmental Disabilities Council since 2003 and has evaluated more than 2,000 individuals with co-occurring mental illness and intellectual disability. She is the recipient of the American Psychiatric Association’s Frank J. Menolascino Award for Excellence in Psychiatric Services for Developmental Disabilities, the Excellence in Contributions to Clinical Practice Award from the National Association for the Dually Diagnosed, and a member of Alpha Omega Alpha Medical Honor Society. She is the recipient of numerous teaching awards and has been awarded more than $3,000,000 in grants and contracts to support her work in dual diagnosis since 2003.\u003c\/p\u003e \u003cp\u003e\u003ci\u003ePaulette Marie Gillig, M.D., Ph.D.\u003c\/i\u003e is Professor of Psychiatry at the Boonshoft School of Medicine, Wright State University, Dayton, Ohio and on the Faculty of the Graduate School.  She has been Ohio Department of Mental Health Professor of Rural and Underserved Populations since 1998, is listed in \u003ci\u003eBest Doctors in America\u003c\/i\u003e, \u003ci\u003eWho's Who in America\u003c\/i\u003e, \u003ci\u003eWho's Who in the World,\u003c\/i\u003e is Distinguished Fellow of the American Psychiatric Association and a member of Alpha Omega Alpha Medical Honor Society. She is the recipient of numerous teaching and has published three books and over 60 articles and book chapters in the several areas of Community (Public) Psychiatry, Psychotherapy, and the Interface between Psychiatry and Neurology.  She is the Section Editor for the journal \u003ci\u003eInnovations in Clinical Neuroscience\u003c\/i\u003e.  She completed residencies in both Neurology and in Psychiatry, and also holds a doctorate in Social Psychology in the area of cognitive processes.\u003c\/p\u003e  Individuals with intellectual disability (ID) often present with behavioral symptoms complicated by limited expressive language skills and undiagnosed medical conditions. Many training programs do not include focused study of individuals with ID, despite the fact that such patients will be seen by virtually every mental health practitioner and that these patients can benefit from the full range of mental health services. In this book, the authors present a framework for competent assessment and treatment of psychiatric disorders in individuals with ID.  \u003cp\u003eThere are no evidence-based principles dedicated to psychotropic medication use in ID, but consensus guidelines address the high prevalence of poly-pharmacy. Altered diagnostic criteria have been published which accommodate less self-report and incorporate collateral information; this book reviews the literature on psychotropic medications, consensus guidelines, and population-specific diagnostic criteria sets.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e\u003ci\u003ePsychiatry of Intellectual Disability\u003c\/i\u003e\u003c\/b\u003e also includes:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eInterviewing techniques and assessment tips for all levels of communicative ability as well as for nonverbal individuals\u003c\/li\u003e \u003cli\u003eAssessment of aggression to determine etiology and formulate a treatment plan\u003c\/li\u003e \u003cli\u003eOverview of types of psychotherapy and suggested alterations for each to increase efficacy\u003c\/li\u003e \u003cli\u003eRelevant legal issues for caregivers and treatment providers\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eThe detective work involved in mental health assessment of individuals with ID is challenging yet rewarding. The highest quality mental health treatment limits hospital days, improves quality of life and often allows individuals to live in the least restrictive environments. \u003cb\u003e\u003ci\u003ePsychiatry of Intellectual Disability\u003c\/i\u003e\u003c\/b\u003e is a must have resource guide for psychiatrists, nurse practitioners, and other prescribers treating patients with ID. It is a supplemental text for psychiatry residents, medical students, psychology graduate students, psychotherapists, counselors, social workers, behavior support specialists and nurses.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989883109605,"sku":"NP9781119993810","price":76.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119993810.jpg?v=1761785782","url":"https:\/\/k12savings.com\/es\/products\/psychiatry-of-intellectual-disability-isbn-9781119993810","provider":"K12savings","version":"1.0","type":"link"}